HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Tol Selected Research

J Tol Research Topics

Disease

6Colorectal Neoplasms (Colorectal Cancer)
03/2011 - 04/2008
2Breast Neoplasms (Breast Cancer)
04/2016 - 01/2016
2Neoplasms (Cancer)
04/2016 - 01/2012
1Tics (Tic)
01/2016
1Cardiotoxicity
01/2016
1Weight Loss (Weight Reduction)
10/2014
1Body Weight (Weight, Body)
10/2014
1Candidiasis (Moniliasis)
01/2012
1Esophageal Squamous Cell Carcinoma
01/2012
1Carcinoma (Carcinomatosis)
01/2012
1Ulcer
08/2008
1Neoplasm Metastasis (Metastasis)
05/2006

Drug/Important Bio-Agent (IBA)

3Bevacizumab (Avastin)FDA Link
12/2010 - 04/2008
2ErbB Receptors (EGF Receptor)IBA
03/2011 - 04/2008
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2011 - 04/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2008 - 04/2008
1Ado-Trastuzumab EmtansineIBA
04/2016
1zirconium-89-trastuzumabIBA
04/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2016
1Trastuzumab (Herceptin)FDA Link
01/2016
1NitrosaminesIBA
01/2012
1MagnesiumIBA
02/2011
1CalciumIBA
02/2011
1Cetuximab (Erbitux)FDA Link
04/2008
1Capecitabine (Xeloda)FDA Link
04/2008

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2010 - 04/2008
1Aftercare (After-Treatment)
10/2014
1Duration of Therapy
10/2014
1Adjuvant Chemotherapy
05/2006
1Neoadjuvant Therapy
05/2006